I-O Optimise, a multinational initiative, will provide valuable real-world insights on the evolving lung cancers* landscape for oncologists and other healthcare professionals, academic researchers, payers, regulators and patients
The External Scientific Committee is a multidisciplinary team of experts that provides robust scientific guidance.
Contribution of data is critical in order for I-O Optimise to provide valuable real-world insights